Current Investment by Areas of Research

Extramural and Intramural Investment by Areas of Research, 2019
These investments are updated each year in May or June and reflect the investments by areas of research for the previous year. The next update will be in May or June of 2021 for Investments by Areas of Research for 2020.

Areas of Research

Extramural Funded

Extramural Specific
Amount ($)

Intramural Research
Amount ($)

Total ($)

Biology 76,406,500 41,293,185 524,430 41,817,615
Cause/Etiology 15,348,000 7,160,475 7,342,015 14,502,490
Treatment 41,900,100 18,774,570 - 18,774,570
Prevention (including Nutrition, Physical Activity, and Tobacco Control) 6,746,750 2,982,278 3,649,877 6,632,155
Early Detection, Diagnosis, and Prognosis 14,738,500 5,880,820 2,173,547 8,054,367
Cancer Control, Survivorship (including quality of life and end of life), and Outcomes Research 27,330,500 15,195,222 4,504,570 19,699,792
Not Categorized 4,032,080 4,032,080 - 4,032,080
Grand Total 186,502,430 95,318,630§ 18,194,439

*Funded Amount - The total value of funding that was awarded to a single group of research or training grants with relevance to a specific area of research and includes funding for some projects that may be minimally related to that type of cancer or area of research.

†Specific Amount - The portion of the total project funding for each individual project, which corresponds to the percent relevance number for that area of research in the project. This number can be found by multiplying the total funding amount by the percent relevance. For example, if the total funding amount is $500,000 and the percent relevance is 50%, the specific amount for the project is $250,000.

‡ Not Categorized - Three award mechanisms are not classified using these categories: Audrey Meyer Mars International Fellowships in Clinical Oncology, Institutional Research Grants, and Master's Training Grants in Clinical Oncology Social Work.

§ The total extramural specific amount represents the research and training grants awarded during 2019. This number may not exactly match the financial reporting for research expenditures for that time.